Black Hawk Acquisition Corp

corporate_fare Company Profile

Black Hawk Acquisition Corp

BKHA·NASDAQ·Life Sciences·CIK 0002000775

Black Hawk Acquisition Corporation is a blank check company that aims to combine with one or more existing businesses or entities. This could involve a merger, exchanging shares, acquiring assets, purchasing shares, reorganizing, or a similar business combination. The company was established in 2023 and operates out of Danville, California.

Black Hawk Acquisition Corp (NASDAQ:BKHA) is a publicly traded company in the Life Sciences sector. Wiseek monitors BKHA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

SPAC Merger Update: Black Hawk Details Governance Breach, Nasdaq Delisting Risk, and High Dilution in Vesicor Biotech Deal (2026-06-11)
Black Hawk Acquisition Corp Secures $300K Convertible Note from Sponsor at Deep Discount for DeSPAC (2026-05-08)
SPAC Faces Delisting Risk Amidst Merger with Pre-Clinical Biopharma, Critical Financing Unsecured (2026-05-01)
Black Hawk Acquisition Corp Faces Nasdaq Delisting Threat Amidst Highly Dilutive Sponsor Financing (2026-04-20)
Black Hawk Acquisition Breaches Nasdaq Listing Rule on Market Value, Faces Delisting Risk (2026-04-01)

Financial Snapshot

Fiscal year ended November 30, 2025

Net Income

$1.33M

Op. Cash Flow

-$650.32K

Operating Income

-$915.51K

Cash & Equivalents

Debt / Equity

0.00×

Source: 10-K · filed 2026-04-28 · accession 0001829126-26-004046

show_chartPrice Chart

Loading chart...

feed BKHA - Latest Insights

Filing Type

Date Range

BKHA

Jun 11, 2026, 6:01 AM EDT

Filing Type: S-4/A

Importance Score:

SPAC Merger Update: Black Hawk Details Governance Breach, Nasdaq Delisting Risk, and High Dilution in Vesicor Biotech Deal

Price at Filing: $11.89

Real-time Price: $11.89

Change: $0 (0%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

May 08, 2026, 4:15 PM EDT

Filing Type: 8-K

Importance Score:

Black Hawk Acquisition Corp Secures $300K Convertible Note from Sponsor at Deep Discount for DeSPAC

Price at Filing: $11.86

Real-time Price: $11.89

Change: +$0.030 (+0.25%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

May 01, 2026, 11:08 AM EDT

Filing Type: S-4/A

Importance Score:

SPAC Faces Delisting Risk Amidst Merger with Pre-Clinical Biopharma, Critical Financing Unsecured

Price at Filing: $11.70

Real-time Price: $11.89

Change: +$0.190 (+2%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Apr 20, 2026, 6:23 PM EDT

Filing Type: 10-Q

Importance Score:

Black Hawk Acquisition Corp Faces Nasdaq Delisting Threat Amidst Highly Dilutive Sponsor Financing

Price at Filing: $11.62

Real-time Price: $11.89

Change: +$0.270 (+2%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Apr 01, 2026, 5:03 PM EDT

Source: Wiseek News

Importance Score:

Black Hawk Acquisition Breaches Nasdaq Listing Rule on Market Value, Faces Delisting Risk

Price at Filing: $11.59

Real-time Price: $11.89

Change: +$0.300 (+3%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Apr 01, 2026, 4:56 PM EDT

Filing Type: 8-K

Importance Score:

Black Hawk Acquisition Corp Receives Nasdaq Delisting Notice for Failing to Meet $50M MVLS Requirement

Price at Filing: $11.59

Real-time Price: $11.89

Change: +$0.300 (+3%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Mar 17, 2026, 5:30 PM EDT

Filing Type: 8-K

Importance Score:

Vesicor Therapeutics Appoints Biotech Veteran Michael Tolentino as CEO Amidst SPAC Merger Uncertainty

Price at Filing: $11.55

Real-time Price: $11.89

Change: +$0.340 (+3%)

Market Cap: $49.386M

Sentiment: Positive

View Wiseek Article

BKHA

Mar 06, 2026, 5:15 PM EST

Source: Wiseek News

Importance Score:

Black Hawk 10-K Flags 'Going Concern' Risk, Adding to Merger Uncertainty

Price at Filing: $11.46

Real-time Price: $11.89

Change: +$0.4299 (+4%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Mar 06, 2026, 5:12 PM EST

Filing Type: 10-K

Importance Score:

Black Hawk Acquisition Corp. Discloses Going Concern Doubt, Material Weakness, and Massive Redemptions in Annual Report

Price at Filing: $11.46

Real-time Price: $11.89

Change: +$0.4299 (+4%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Mar 04, 2026, 8:21 PM EST

Filing Type: S-4/A

Importance Score:

SPAC Merger with Pre-Clinical Biopharma Faces Critical Financing Uncertainty & Nasdaq Delisting Risk

Price at Filing: $11.46

Real-time Price: $11.89

Change: +$0.4299 (+4%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

BKHA

Feb 19, 2026, 3:13 PM EST

Filing Type: 8-K

Importance Score:

Black Hawk Acquisition Corp Secures Up to $300K Convertible Note from Sponsor for DeSPAC Working Capital

Price at Filing: $11.60

Real-time Price: $11.89

Change: +$0.290 (+3%)

Market Cap: $49.386M

Sentiment: Neutral

View Wiseek Article

BKHA

Feb 03, 2026, 1:07 PM EST

Filing Type: 8-K

Importance Score:

Black Hawk Acquisition Target Vesicor Appoints New CFO and Director Following Prior CFO's Passing

Price at Filing: $11.40

Real-time Price: $11.89

Change: +$0.490 (+4%)

Market Cap: $49.386M

Sentiment: Neutral

View Wiseek Article

BKHA

Jan 22, 2026, 9:44 PM EST

Filing Type: S-4/A

Importance Score:

SPAC Announces Merger with Pre-Revenue Biopharma Vesicor Amidst High Redemptions and Nasdaq Delisting Risk

Price at Filing: $11.50

Real-time Price: $11.89

Change: +$0.390 (+3%)

Market Cap: $49.386M

Sentiment: Negative

View Wiseek Article

corporate_fare Company Profile